The Public Health and Economic Issue of AMR

In this podcast hosted by Peter Bak and Back Bay Life Science Advisors in January 2022,  Antabio’s CEO Marc Lemonnier looks at the pressing global issue of AMR, the clinical landscape of innovative antibiotic therapies and the various pull incentives being implemented to revitalize the business model of antimicrobial R&D.